Newlink Genetics reported -7731000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agenus AGEN:US $ -35.46M 18.57M
Bristol Myers Squibb BMY:US $ 2553M 90M
Capricor Therapeutics CAPR:US $ -7.83M 1.44M
Celldex Therapeutics CLDX:US $ -23.26M 2.92M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M
Intrexon XON:US $ -17.9M 2.59M
Merk MRK:US $ 5569M 1994M
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Newlink Genetics NLNK:US -7731000 1.16M
Pfizer PFE:US $ 9873M 5297M
Prothena PRTA:US -37944000 4.85M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Vascular Biogenics VBLT:US -10564000 1.45M
YTE INCY:US $ 116.54M 5.81M